An agreement between NeoStrata and Johnson & Johnson Consumer brings NeoStrata’s research and innovations in the area of alpha hydroxyl acids (AHA) into the Johnson & Johnson portfolio.
Considered a standard in anti-aging technologies in the beauty category, AHAs are clinically proven and able to meet the needs of a variety of different skin types.
“Drs Ruey Yu and Eugene Van Scott formed NeoStrata in 1988 and continue to make significant contributions to the science of skincare,” Jorge Mesquite, worldwide chairman, consumer, Johnson & Johnson says in a media release from Johnson & Johnson.
“NeoStrata’s legacy in dermocosmetics will complement our global Consumer portfolio and enable us to deliver advanced skin care brands to consumers around the world. NeoStrata and Johnson & Johnson share a strong history of innovation, and together we will work to discover important new skin care solutions grounded in deep human insights and compelling science. We look forward to working closely with NeoStrata’s distributors around the world and having their outstanding team of employees join Johnson & Johnson Consumer later this year.”
Johnson & Johnson Consumer expects the acquisition to close in the first half of the year, according to the release.
[Source(s): Johnson & Johnson, PR Newswire]